ARKF vs. IMRX
ARKF (ARK Fintech Innovation ETF) is Blockchain fund actively managed by ARK, while IMRX (Immuneering Corporation) is a stock. Over the past 3 years, ARKF returned 23.97%/yr vs -24.01%/yr for IMRX. At a 0.27 correlation, their price movements are largely independent.
Performance
ARKF vs. IMRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKF achieves a -18.31% return, which is significantly higher than IMRX's -36.32% return.
ARKF
- 1D
- 0.00%
- 1M
- -5.76%
- YTD
- -18.31%
- 6M
- -21.31%
- 1Y
- -11.87%
- 3Y*
- 23.97%
- 5Y*
- -5.06%
- 10Y*
- —
IMRX
- 1D
- 1.70%
- 1M
- -22.12%
- YTD
- -36.32%
- 6M
- -31.09%
- 1Y
- 113.78%
- 3Y*
- -24.01%
- 5Y*
- —
- 10Y*
- —
ARKF vs. IMRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ARKF ARK Fintech Innovation ETF | -18.31% | 28.67% | 34.34% | 93.27% | -65.07% | -21.35% |
IMRX Immuneering Corporation | -36.32% | 199.09% | -70.07% | 51.55% | -70.01% | -17.08% |
Correlation
The correlation between ARKF and IMRX is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2021 | 0.27 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKF vs. IMRX — Risk / Return Rank
ARKF
IMRX
ARKF vs. IMRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Fintech Innovation ETF (ARKF) and Immuneering Corporation (IMRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARKF | IMRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.28 | ||
| Sortino ratioReturn per unit of downside risk | -2.33 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.29 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | -0.31 | 1.98 | -2.29 |
| Martin ratioReturn relative to average drawdown | -0.57 | 3.30 | -3.87 |
Loading charts...
Drawdowns
ARKF vs. IMRX - Drawdown Comparison
The maximum ARKF drawdown since its inception was -78.63%, smaller than the maximum IMRX drawdown of -96.86%. Use the drawdown chart below to compare losses from any high point for ARKF and IMRX.
Loading charts...
Drawdown Indicators
| ARKF | IMRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.63% | -96.86% | +18.23% |
Max Drawdown (1Y)Largest decline over 1 year | -38.50% | -57.67% | +19.17% |
Max Drawdown (3Y)Largest decline over 3 years | -38.50% | -90.98% | +52.48% |
Max Drawdown (5Y)Largest decline over 5 years | -75.30% | — | — |
Current DrawdownCurrent decline from peak | -38.77% | -87.24% | +48.47% |
Average DrawdownAverage peak-to-trough decline | -34.95% | -77.61% | +42.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.00% | 34.56% | -13.56% |
Volatility
ARKF vs. IMRX - Volatility Comparison
The current volatility for ARK Fintech Innovation ETF (ARKF) is 10.36%, while Immuneering Corporation (IMRX) has a volatility of 33.75%. This indicates that ARKF experiences smaller price fluctuations and is considered to be less risky than IMRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKF | IMRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.36% | 33.75% | -23.39% |
Volatility (6M)Calculated over the trailing 6-month period | 25.14% | 79.00% | -53.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.69% | 124.22% | -90.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.87% | 114.45% | -71.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.77% | 114.45% | -74.68% |
Dividends
ARKF vs. IMRX - Dividend Comparison
ARKF's dividend yield for the trailing twelve months is around 0.11%, while IMRX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
ARKF ARK Fintech Innovation ETF | 0.11% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.37% | 1.25% |
IMRX Immuneering Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
ARKF and IMRX have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IMRX has higher volatility (33.75%) compared to ARKF (10.36%). In terms of maximum drawdown, ARKF dropped -78.63% vs IMRX's -96.86%.
IMRX currently has the higher Sharpe Ratio (0.92 vs -0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKF and IMRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer